BIOLINQ Trademark

Trademark Overview

On Monday, January 23, 2023, a trademark application was filed for BIOLINQ with the United States Patent and Trademark Office. The USPTO has given the BIOLINQ trademark a serial number of 97764177. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Wednesday, September 18, 2024. This trademark is owned by Biolinq Incorporated. The BIOLINQ trademark is filed in the Medical Instrument Products category with the following description:

Wearable monitors used to measure biometric data for medical use; Glucose meters; wearable devices, namely, continuous glucose sensors for monitoring blood glucose for medical purposes
biolinq

General Information

Serial Number97764177
Word MarkBIOLINQ
Filing DateMonday, January 23, 2023
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateWednesday, September 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, October 31, 2023

Trademark Statements

Description of MarkThe mark consists of the word "BIOLINQ" in lower case, fanciful font.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesWearable monitors used to measure biometric data for medical use; Glucose meters; wearable devices, namely, continuous glucose sensors for monitoring blood glucose for medical purposes

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSunday, February 12, 2023
Primary Code010
First Use Anywhere DateFriday, May 12, 2023
First Use In Commerce DateFriday, May 12, 2023

Trademark Owner History

Party NameBiolinq Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameBiolinq Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Thursday, January 26, 2023NEW APPLICATION ENTERED
Sunday, February 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 22, 2023ASSIGNED TO EXAMINER
Saturday, September 23, 2023NON-FINAL ACTION WRITTEN
Saturday, September 23, 2023NON-FINAL ACTION E-MAILED
Saturday, September 23, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 26, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 26, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, September 26, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 26, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, September 26, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 11, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 31, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 31, 2023PUBLISHED FOR OPPOSITION
Friday, June 21, 2024USE AMENDMENT FILED
Friday, June 21, 2024TEAS STATEMENT OF USE RECEIVED
Friday, June 21, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, December 26, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 21, 2024SOU EXTENSION 1 FILED
Wednesday, August 14, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, September 18, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, September 18, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, August 14, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 21, 2024SOU EXTENSION 1 GRANTED

Related Keywords

biolinq glucose medical wearable continuous sensors monitoring purposes blood namely meters